A New York couple who said Botox treatment of their son's cerebral palsy left him with life-threatening complications and sued its manufacturer have been awarded $6.75 million.
The federal jury verdict in U.S. District Court in Burlington, Vermont, came Thursday, three days after the announcement drugmaker Actavis would acquire Botox maker Allergan for $66 billion. The acquisition is one of the biggest announced this year.
A lawyer for Mineville, New York, residents Lori and Kevin Drake says 7-year-old Joshua Drake suffered calf spasms due to mild cerebral palsy until he got Botox injections to treat them at a Burlington hospital. Attorney Ray Chester says Joshua has since developed epilepsy and must have an aide with him at all times in case he needs life-saving medications during a seizure.
Irvine, California-based Allergan hasn't responded to phone messages seeking comment.